ToxCast Endpoints |
---|
Assay Name | Tissue | Target Gene ID | Target HGNC Symbol | Target UniProt ID | Response | AC50 value |
---|---|---|---|---|---|---|
LTEA_HepaRG_ABCB11 | Liver | 8647 | ABCB11 | O95342 | Inhibitory | 22.38 μM |
LTEA_HepaRG_AFP | Liver | 174 | AFP | P02771 | Inhibitory | 34.04 μM |
LTEA_HepaRG_CYP1A1 | Liver | 1543 | CYP1A1 | P04798 | Activatory | 20.34 μM |
LTEA_HepaRG_CYP1A2 | Liver | 1544 | CYP1A2 | P05177 | Activatory | 36.97 μM |
LTEA_HepaRG_CYP2B6 | Liver | 1555 | CYP2B6 | P20813 | Activatory | 9.15 μM |
LTEA_HepaRG_CYP2E1 | Liver | 1571 | CYP2E1 | P05181 | Inhibitory | 16.35 μM |
LTEA_HepaRG_CYP7A1 | Liver | 1581 | CYP7A1 | P22680 | Inhibitory | 9.92 μM |
LTEA_HepaRG_FABP1 | Liver | 2168 | FABP1 | P07148 | Inhibitory | 24.95 μM |
LTEA_HepaRG_FASN | Liver | 2194 | FASN | P49327 | Inhibitory | 25.12 μM |
LTEA_HepaRG_FMO3 | Liver | 2328 | FMO3 | P31513 | Inhibitory | 25.10 μM |
LTEA_HepaRG_FOXO3 | Liver | 2309 | FOXO3 | O43524 | Inhibitory | 18.01 μM |
LTEA_HepaRG_GADD45B | Liver | 4616 | GADD45B | O75293 | Inhibitory | 50.00 μM |
LTEA_HepaRG_GADD45G | Liver | 10912 | GADD45G | O95257 | Inhibitory | 26.05 μM |
LTEA_HepaRG_HMGCS2 | Liver | 3158 | HMGCS2 | P54868 | Inhibitory | 19.26 μM |
LTEA_HepaRG_KRT19 | Liver | 3880 | KRT19 | P08727 | Inhibitory | 30.78 μM |
LTEA_HepaRG_LPL | Liver | 4023 | LPL | P06858 | Inhibitory | 50.00 μM |
LTEA_HepaRG_PDK4 | Liver | 5166 | PDK4 | Q16654 | Inhibitory | 9.92 μM |
LTEA_HepaRG_PEG10 | Liver | 23089 | PEG10 | Q86TG7 | Inhibitory | 33.70 μM |
LTEA_HepaRG_SLC22A1 | Liver | 6580 | SLC22A1 | O15245 | Inhibitory | 50.00 μM |
LTEA_HepaRG_UGT1A1 | Liver | 54658 | UGT1A1 | P22309 | Activatory | 26.66 μM |
Assay Name | Tissue | Target Gene ID | Target HGNC Symbol | Target UniProt ID | Response | AC50 value |
---|---|---|---|---|---|---|
CCTE_Deisenroth_AIME_384WELL_LUC_Active | Mammary Gland/Breast | 2099 | ESR1 | P03372 | Gain | 11.90 μM |
CCTE_Deisenroth_AIME_384WELL_LUC_Inactive | Mammary Gland/Breast | 2099 | ESR1 | P03372 | Gain | 15.17 μM |
CCTE_Deisenroth_5AR_NBTE_ratio | Kidney | 6716 | SRD5A2 | Inhibitory | 49.95 μM | |
CCTE_GLTED_hTBG | 6906 | SERPINA7 | Loss | 35.25 μM | ||
CCTE_GLTED_hTTR_0.125uM | 7276 | TTR | Loss | 0.18 μM | ||
NVS_TR_hDAT | 6531 | SLC6A3 | Q01959 | Loss | 19.50 μM | |
ATG_Ahr_CIS | Liver | 196 | AHR | P35869 | Inhibitory | 67.85 μM |
ATG_ERE_CIS | Liver | 2099 | ESR1 | P03372 | Activatory | 12.77 μM |
ATG_PXRE_CIS | Liver | 8856 | NR1I2 | O75469 | Inhibitory | 46.66 μM |
ATG_ERa_TRANS | Liver | 2099 | ESR1 | P03372 | Gain | 6.68 μM |
BSK_LPS_PGE2 | Vascular | 5732 | PTGER2 | P43116 | Inhibitory | 7.16 μM |
ATG_trERa_XSP2 | Liver | 101933533 | ESR1 | B6E1V9 | Gain | 13.18 μM |
ATG_hERb_XSP2 | Liver | 2100 | ESR2 | Q92731 | Gain | 10.60 μM |
ATG_zfER1_XSP2 | Liver | 259252 | esr1 | P57717 | Gain | 81.06 μM |
ATG_chERa_XSP2 | Liver | 396099 | ESR1 | P06212 | Gain | 17.68 μM |
ATG_zfER2a_XSP2 | Liver | 317734 | esr2a | Q7ZU32 | Gain | 6.80 μM |
ATG_zfER2b_XSP2 | Liver | 317733 | esr2b | Q5PR29 | Gain | 39.67 μM |
ATG_hERa_XSP2 | Liver | 2099 | ESR1 | P03372 | Gain | 9.48 μM |
ATG_frER2_XSP2 | Liver | 100174814 | esr2.L | A0A1L8FA50 | Gain | 10.60 μM |
ATG_mPPARg_XSP2 | Liver | 19016 | Pparg | P37238 | Gain | 55.51 μM |
ATG_hPPARg_XSP2 | Liver | 5468 | PPARG | P37231 | Gain | 100.00 μM |
ATG_trERa_XSP2 | Liver | 101933533 | ESR1 | B6E1V9 | Gain | 25.84 μM |
ATG_hERb_XSP2 | Liver | 2100 | ESR2 | Q92731 | Gain | 26.09 μM |
ATG_zfER1_XSP2 | Liver | 259252 | esr1 | P57717 | Gain | 100.00 μM |
ATG_chERa_XSP2 | Liver | 396099 | ESR1 | P06212 | Gain | 27.12 μM |
ATG_zfER2a_XSP2 | Liver | 317734 | esr2a | Q7ZU32 | Gain | 11.01 μM |
ATG_zfER2b_XSP2 | Liver | 317733 | esr2b | Q5PR29 | Gain | 61.33 μM |
ATG_hERa_XSP2 | Liver | 2099 | ESR1 | P03372 | Gain | 9.97 μM |
ATG_frER2_XSP2 | Liver | 100174814 | esr2.L | A0A1L8FA50 | Gain | 22.12 μM |
ATG_hPPARg_XSP2 | Liver | 5468 | PPARG | P37231 | Gain | 72.09 μM |
TOX21_ERa_BLA_Agonist_ratio | Kidney | 2099 | ESR1 | P03372 | Gain | 7.51 μM |
TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2 | Breast | 2099 | ESR1 | P03372 | Loss | 14.25 μM |
TOX21_AhR_LUC_Agonist | Liver | 196 | AHR | P35869 | Gain | 0.71 μM |
TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 | Breast | 367 | AR | P10275 | Loss | 3.56 μM |
TOX21_TSHR_HTRF_Agonist_ratio | Kidney | 7253 | TSHR | Gain | 1.37 μM | |
TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2 | Breast | 2099 | ESR1 | P03372 | Loss | 29.04 μM |
TOX21_PGC_ERR_LUC_Agonist | Kidney | 2101 | ESRRA | P11474 | Gain | 3.75 μM |
TOX21_ERb_BLA_Agonist_ratio | Kidney | 2100 | ESR2 | Q92731 | Gain | 3.25 μM |
TOX21_PR_BLA_Antagonist_ratio | Kidney | 5241 | PGR | P06401 | Loss | 35.32 μM |
TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780 | Breast | 2099 | ESR1 | P03372 | Gain | 1.08 μM |
TOX21_PXR_LUC_Agonist | Liver | 8856 | NR1I2 | O75469 | Gain | 45.55 μM |
TOX21_p450_CYP3A4_Antagonist | 1576 | CYP3A4 | P08684 | Loss | 5.39 μM | |
TOX21_p450_CYP2D6_Antagonist | 1565 | CYP2D6 | P10635 | Loss | 3.37 μM | |
TOX21_p450_CYP2C19_Antagonist | 1557 | CYP2C19 | P33261 | Loss | 6.47 μM | |
TOX21_p450_CYP2C9_Antagonist | 1559 | CYP2C9 | P11712 | Loss | 21.78 μM | |
TOX21_p450_CYP1A2_Antagonist | 1544 | CYP1A2 | P05177 | Loss | 0.48 μM | |
TOX21_ERa_BLA_Agonist_ratio | Kidney | 2099 | ESR1 | P03372 | Gain | 57.39 μM |
TOX21_ERa_LUC_VM7_Agonist | Breast | 2099 | ESR1 | P03372 | Gain | 26.23 μM |
TOX21_AhR_LUC_Agonist | Liver | 196 | AHR | P35869 | Gain | 0.81 μM |
TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 | Breast | 367 | AR | P10275 | Loss | 3.91 μM |
TOX21_CAR_LUC_Agonist | Liver | 9970 | NR1I3 | Q14994 | Gain | 20.31 μM |
TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2 | Breast | 2099 | ESR1 | P03372 | Loss | 15.68 μM |
TOX21_PR_BLA_Antagonist_ratio | Kidney | 5241 | PGR | P06401 | Loss | 36.05 μM |
TOX21_PXR_LUC_Agonist | Liver | 8856 | NR1I2 | O75469 | Gain | 39.26 μM |
TOX21_p450_CYP3A4_Antagonist | 1576 | CYP3A4 | P08684 | Loss | 8.62 μM | |
TOX21_p450_CYP2D6_Antagonist | 1565 | CYP2D6 | P10635 | Loss | 3.23 μM | |
TOX21_p450_CYP2C19_Antagonist | 1557 | CYP2C19 | P33261 | Loss | 7.95 μM | |
TOX21_p450_CYP2C9_Antagonist | 1559 | CYP2C9 | P11712 | Loss | 13.43 μM | |
TOX21_p450_CYP1A2_Antagonist | 1544 | CYP1A2 | P05177 | Loss | 0.70 μM |
Assay Name | Tissue | Target Gene ID | Target HGNC Symbol | Target UniProt ID | Response | AC50 value |
---|---|---|---|---|---|---|
UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist | Bone | 367 | AR | P10275 | Loss | 11.62 μM |
UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist | Bone | 367 | AR | P10275 | Loss | 9.92 μM |
ACEA_ER_80hr | Breast | 2099 | ESR1 | P03372 | Gain | 9.92 μM |
APR_HepG2_CellCycleArrest_72hr | Liver | Inhibitory | 66.73 μM | |||
OT_ER_ERaERb_0480 | Kidney | 2100|2099 | ESR2|ESR1 | Q92731|P03372 | Gain | 50.00 μM |
OT_ER_ERaERb_1440 | Kidney | 2100|2099 | ESR2|ESR1 | Q92731|P03372 | Gain | 67.09 μM |
OT_ER_ERbERb_0480 | Kidney | 2100 | ESR2 | Q92731 | Gain | 68.43 μM |
OT_ER_ERbERb_1440 | Kidney | 2100 | ESR2 | Q92731 | Gain | 61.87 μM |
OT_ERa_GFPERaERE_0120 | Cervix | 2099 | ESR1 | P03372 | Gain | 50.00 μM |
OT_ERa_GFPERaERE_0480 | Cervix | 2099 | ESR1 | P03372 | Gain | 37.18 μM |
OT_FXR_FXRSRC1_0480 | Kidney | 6714|9971 | NR1H4|SRC | P12931|Q96RI1 | Gain | 63.15 μM |
ACEA_AR_antagonist_80hr | Prostate | 367 | AR | P10275 | Loss | 2.69 μM |
TOX21_ERa_BLA_Agonist_ch1 | Kidney | Loss | 2.35 μM | |||
TOX21_ERa_BLA_Agonist_ch2 | Kidney | Gain | 37.87 μM | |||
TOX21_TSHR_HTRF_Agonist_ch1 | Kidney | Loss | 1.67 μM | |||
TOX21_TSHR_HTRF_Antagonist_ch2 | Kidney | Loss | 45.55 μM | |||
TOX21_HDAC_LUC_Antagonist | Colon | 3065 | HDAC1 | Q13547 | Loss | 45.55 μM |
TOX21_ERb_BLA_Agonist_ch2 | Kidney | Gain | 3.91 μM | |||
TOX21_PR_BLA_Antagonist_ch2 | Kidney | Loss | 66.57 μM | |||
TOX21_ERa_BLA_Agonist_ch2 | Kidney | Gain | 61.92 μM | |||
TOX21_TSHR_HTRF_Antagonist_ch2 | Kidney | Loss | 45.97 μM | |||
TOX21_HDAC_LUC_Antagonist | Colon | 3065 | HDAC1 | Q13547 | Loss | 56.47 μM |
TOX21_ERb_BLA_Agonist_ch2 | Kidney | Gain | 33.60 μM |
Assay Name | Tissue | Response | AC50 value |
---|---|---|---|
BSK_SAg_Proliferation | Vascular | Inhibitory | 11.75 μM |
ACEA_AR_antagonist_AUC_viability | Prostate | Loss | 2.03 μM |
TICToK is a database of tattoo ink chemicals compiled from different regulatory resources. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on tattoo ink chemicals is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.